NLRP3 inflammasome in sepsis: don't overlook the small steps-they can make a big difference!

Felicie Belicard1,2, Karin Tarte1,2, Jean-Marc Tadié1,2,3

  • 1Department of Infectious Diseases and Intensive Care Unit, CHU Rennes, 35000 Rennes, France.

PubMed

Insights

Persistent NLRP3 activation in sepsis drives myeloid-derived suppressor cell expansion and elevates Interleukin-10 (IL-10) levels. This highlights a key pathway in sepsis-induced immune dysregulation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Critical Care Medicine

Background:

  • Sepsis involves complex immune dysregulation.
  • NLRP3 inflammasome activation is implicated in inflammatory diseases.
  • Myeloid-derived suppressor cells (MDSCs) play a role in immune suppression.